Skip to search formSkip to main contentSkip to account menu

Zanamivir

Known as: ATC code J05AH01, ATCvet code QJ05AH01, Relenza 
Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It… 
Wikipedia (opens in a new tab)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Bacterial infections are still one of the main causes of disease around the world. For this reason, the early diagnosis of an… 
Review
2016
Review
2016
All patients received the following treatments: • Antiviral therapy in recommended doses (neuraminidase inhibitors Relenza… 
2012
2012
IN VITRO METHODS TO PREDICT AEROSOL DRUG DEPOSITION IN NORMAL ADULTS By Renishkumar R. Delvadia, B. Pharm., M.Pharm. A… 
2010
2010
  • R. Webster
  • Biographical Memoirs of Fellows of the Royal…
  • 2010
  • Corpus ID: 72007700
A novel influenza virus of swine origin that emerged in Mexico in April 2009 has spread globally in humans and caused the first… 
Review
2007
Review
2007
Deutschland sowie Faktoren, die zu diesem Verhalten führen, identifiziert werden. In den vom RKI durchgeführten telefonischen… 
2006
2006
Although influenza pandemics have plagued mankind for centuries, a pandemic resulting from the current H5N1 threat would be a… 
2000
2000
[Glaxo Wellcome responds:] Deena Ages notes that the patient information pamphlet for Relenza does not include the statement in…